1. ChemInform Abstract: Ligand‐Based Design, Synthesis, and Pharmacological Evaluation of 3‐Methoxyquinoxalin‐2‐carboxamides as Structurally Novel Serotonin Type‐3 Receptor Antagonists. Issue 1 (3rd January 2013) Authors: Mahesh, Radhakrishnan; Devadoss, Thangaraj; Dhar, Arghya Kusum; Venkatesh, Sudali Muthu; Mundra, Sourabh; Pandey, Dilip Kumar; Bhatt, Shvetank; Jindal, Ankur Kumar Journal: ChemInform Issue: Volume 44:Issue 1(2013) Page Start: no Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design, Synthesis and Evaluation of Antidepressant Activity of Novel 2‐Methoxy 1, 8 Naphthyridine 3‐Carboxamides as 5‐HT3 Receptor Antagonists. (14th March 2014) Authors: Mahesh, Radhakrishnan; Dhar, Arghya Kusum; Jindal, Ankur; Bhatt, Shvetank Journal: Chemical biology & drug design Issue: Volume 83:Number 5(2014:May) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Design, Synthesis, and Pharmacological Evaluation of Novel 2‐(4‐substituted piperazin‐1‐yl)1, 8 Naphthyridine 3‐Carboxylic Acids as 5‐HT3 Receptor Antagonists for the Management of Depression. (26th June 2014) Authors: Dhar, Arghya K.; Mahesh, Radhakrishnan; Jindal, Ankur; Devadoss, Thangaraj; Bhatt, Shvetank Journal: Chemical biology & drug design Issue: Volume 84:Number 6(2014:Dec.) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora. (1st May 2022) Authors: Alharbi, Khalid Saad; Singh, Yogendra; Hassan almalki, Waleed; Rawat, Sushama; Afzal, Obaid; Alfawaz Altamimi, Abdulmalik Saleh; Kazmi, Imran; Al-Abbasi, Fahad A.; Alzarea, Sami I.; Singh, Sachin Kumar; Bhatt, Shvetank; Chellappan, Dinesh Kumar; Dua, Kamal; Gupta, Gaurav Journal: Chemico-biological interactions Issue: Volume 358(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of ecDNA: A mechanism that directs tumorigenesis in cancer drug Resistance-A review. (25th August 2022) Authors: Ashique, Sumel; Upadhyay, Aakash; Garg, Ashish; Mishra, Neeraj; Hussain, Afzal; Negi, Poonam; Hing, Goh Bey; Bhatt, Shvetank; Ali, Md Khadem; Gowthamarajan, Kuppusamy; Singh, Sachin Kumar; Gupta, Gaurav; Chellappan, Dinesh Kumar; Dua, Kamal Journal: Chemico-biological interactions Issue: Volume 363(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Molecular modifications by regulating cAMP signaling and oxidant-antioxidant defence mechanisms, produce antidepressant-like effect: A possible mechanism of etazolate aftermaths of impact accelerated traumatic brain injury in rat model. (December 2017) Authors: Jindal, Ankur; Mahesh, Radhakrishnan; Bhatt, Shvetank; Pandey, Dilip Journal: Neurochemistry international Issue: Volume 111(2017) Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Piperazine Analogs of Naphthyridine‐3‐carboxamides and Indole‐2‐carboxamides: Novel 5‐HT3 Receptor Antagonists with Antidepressant‐Like Activity. Issue 1 (January 2015) Authors: Dhar, Arghya K.; Mahesh, Radhakrishnan; Jindal, Ankur; Bhatt, Shvetank Journal: Archiv der Pharmazie Issue: Volume 348:Issue 1(2015:Jan.) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Role of oxidative stress in depression. Issue 7 (July 2020) Authors: Bhatt, Shvetank; Nagappa, Anantha Naik; Patil, Chandragouda R. Journal: Drug discovery today Issue: Volume 25:Issue 7(2020) Page Start: 1270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of reactive oxygen species in the progression of Alzheimer's disease. Issue 3 (March 2021) Authors: Bhatt, Shvetank; Puli, Lakshman; Patil, Chandragauda R. Journal: Drug discovery today Issue: Volume 26:Issue 3(2021) Page Start: 794 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases. Issue 5 (May 2022) Authors: Mishra, Neeraj; Ashique, Sumel; Garg, Ashish; Rai, Vineet Kumar; Dua, Kamal; Goyal, Amit; Bhatt, Shvetank Journal: Drug discovery today Issue: Volume 27:Issue 5(2022) Page Start: 1431 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗